Phase 2 Start~month
Phase 2 Start: A Phase 2a Randomized, Double-Blind Study to Evaluate the Safety, Biomarker Activity, and Microglial
- Indication
- ALS (Amyotrophic Lateral Sclerosis); ALS; ALS - Amyotrophic Lateral Sclerosis
Other upcoming events for TLSA
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.